NEW SITE — FASTER TURNAROUND, MORE LABS. READ ON
Free peptide testing

Ordered peptides from Laicuinuo LCN? Mail in a sample (US only) and let us test it.

Test my supply
+4 more ↓
57%
Finnrick rating
#417 of 457 ranked vendors
24 of 43 classifiable tests passed
methodology · Purity focus
Finnrick analysis

Laicuinuo LCN's purity-focus record is strongest on Tirzepatide, where identity and high purity are fairly consistent but fill swings are the main drag. Retatrutide is more dispersed and recently worse, with two newest samples showing identity/no-active failures after earlier clean certificates, so batch gaps and the two-peptide catalog leave uncertainty.

methodology →
vendor intelligence report
Vendor Intelligence Report: Laicuinuo LCN

Corporate records point to a UK Xingruida wrapper in strike-off posture, while HK/CN registry searches do not confirm the storefront’s branding. Mirrored domains, shared infrastructure, and direct-payment rails create the authentication story behind the lab numbers.

17 pages4 risk factors assessed2 Jul 2026
read the report
Rating trend
CUMULATIVE FINNRICK RATING
83%+65%+48%+30%+<30%3 Oct 2025: 63%17 Oct 2025: 65%23 Oct 2025: 56%23 Oct 2025: 57%23 Oct 2025: 57%24 Oct 2025: 57%24 Oct 2025: 57%18 Nov 2025: 57%6 Dec 2025: 56%7 Jan 2026: 57%20 Feb 2026: 58%20 Feb 2026: 59%2 Mar 2026: 55%2 Mar 2026: 61%2 Mar 2026: 62%2 Mar 2026: 62%2 Mar 2026: 62%5 Mar 2026: 63%19 Mar 2026: 63%19 Mar 2026: 63%5 May 2026: 62%11 May 2026: 62%2 Jun 2026: 61%10 Jul 2026: 60%13 Jul 2026: 62%13 Jul 2026: 62%20 Jul 2026: 62%20 Jul 2026: 61%2 Aug 2026: 60%3 Aug 2026: 60%25 Aug 2026: 60%25 Aug 2026: 59%4 Sep 2026: 59%5 Sep 2026: 59%5 Sep 2026: 58%15 Sep 2026: 58%16 Sep 2026: 57%24 Sep 2026: 59%24 Sep 2026: 58%24 Sep 2026: 57%3 Oct 2026: current 57%63%58%57%Oct 25Oct 26
Free peptide testing

Ordered peptides from Laicuinuo LCN? Mail in a sample (US only) and let us test it.

Test my supply
Laicuinuo LCN test history
COA-backed lab tests
DateResultTestLabPurityDosageLabelCOA
24 Sep 2026
Fail
BPC-157
lab nameView COA
24 Sep 2026
Fail
GHK-Cu
lab nameView COA
24 Sep 2026
Fail
Tirzepatide
lab nameView COA
16 Sep 2026
Fail
Tirzepatide
lab nameView COA
15 Sep 2026
Pass
GHK-Cu
lab nameView COA
5 Sep 2026
Fail
Retatrutide
lab nameView COA
5 Sep 2026
Fail
Tesamorelin
lab nameView COA
4 Sep 2026
Pass
GHK-Cu
lab nameView COA
25 Aug 2026
Fail
Retatrutide
lab nameView COA
25 Aug 2026
Fail
Retatrutide
lab nameView COA
1-10 of 43

About Laicuinuo LCN test results from Finnrick

Laicuinuo LCN is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 6 peptides and 43 tests, including ratings, observed price signals, recent test dates, and correction history where available.

Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.

The most visible Laicuinuo LCN peptides in this dataset are BPC-157 (3 tests), CJC-1295 (3 tests) and GHK-Cu (4 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.

Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 43 recent tests.

Corrections
No corrections.
Free peptide testing

Ordered peptides from Laicuinuo LCN? Mail in a sample (US only) and let us test it.

Test my supply